ABSTRACT: Metabolic studies utilizing stable isotope tracer in humans have typically used intravenous tracer infusions and venous blood sampling. These studies explore subcutaneous infusion of isotope and "finger stick" capillary blood sampling to measure glucose turnover. Five subjects received simultaneous 8-h infusions of glucose labeled with isotope: [1-13 C]glucose subcutaneously and [6,6-2 H 2 ]glucose intravenously. At regular intervals, venous and finger stick blood specimens were obtained. Finger stick blood was applied to filter paper. Substrate and isotopic steady state was reached after 7.0 h with both routes of infusion. The isotopic enrichments of finger stick and venous specimens did not differ significantly for the subcutaneously infused [1-
T raditionally, isotope dilution kinetic studies of glucose, FFA, and amino acid metabolism in humans have primarily used intravenous infusion (and oral administration when tracing enteral absorption) of compounds labeled with stable isotopes and measurement of substrate enrichment in venous blood (1, 2) . Intravenous infusion and sampling enables rapid and direct introduction of labeled substrate into the intravascular mixing pool and easy blood sampling. Intravenous access, however, requires that subjects be studied in an inpatient or outpatient clinical research setting to monitor and manage the intravenous infusion and sampling sites. Additionally, such study conditions dramatically decrease the subject's normal activity during the period of study.
The purpose of this study was to evaluate the validity of the use of subcutaneous infusion of tracer and a "finger stick" blood sampling method to measure glucose kinetics by comparing these results with data obtained using a simultaneous intravenous infusion and blood sampling of a second glucose tracer, the current "gold standard" for this type of study. Were such a model using subcutaneous infusion and finger stick sampling successful, it would provide a methodology to study substrate kinetics outside of the metabolic research unit under more real-life conditions.
METHODS

Subjects.
The protocol was reviewed and approved by the Institutional Review Board for Human Subject Research at Baylor College of Medicine in Houston, TX. Twelve healthy subjects, five females and seven males, were recruited by newspaper advertisement or by word of mouth. The mean subject age was 25.1 Ϯ 1.2 y and mean body mass index was 22.9 Ϯ 0.8 kg/m 2 . All subjects were healthy and had a normal physical examination and screening laboratory studies, including Hb and chemistry panel, and, in all women, a negative pregnancy test. Written consent was obtained at the screening visit or on study day before beginning the protocol.
Tracers. Sterile and pyrogen-free [6,6-2 H 2 ]glucose (99 atom% 2 H) and [1- 13 C]glucose (99 atom % 13 C) were purchased from Cambridge Isotope Laboratories (Andover, MA). The stable isotopes were retested for sterility and pyrogenicity by the Investigational Pharmacy at Texas Children's Hospital. For each subject, [6,6-2 H 2 ]glucose was mixed with sterile 0.9% saline to deliver isotope at a rate of 0.04 mg/kg ⅐ min (0.22 mol ⅐ kg Ϫ1 ⅐ min
Ϫ1
). [1- 13 C]glucose was mixed with sterile water to a concentration of 10%. The glucose concentration of all infusates was verified using a glucose oxidase method (YSI glucose analyzer; YSI Inc., Yellow Springs, OH). The stable isotope solutions for intravenous or subcutaneous infusion were prepared using sterile technique, following which they were filtered (0.01 m, Millipore Corporation, Inc. Bedford, MA), stored in sterile syringes, and kept refrigerated at 4°C until used within 36 h of preparation.
Subcutaneous infusion pumps. The [1-13 C]glucose tracer was infused subcutaneously using MiniMed 508 insulin pumps (MiniMed, Sylmar, CA) with sterile, disposable MiniMed Sof-set infusion sets consisting of a syringe connection hub, tubing, and a 1-cm subcutaneous infusion delivery needle, and sterile, disposable 3.0-mL MiniMed reservoirs.
Glucose extraction from filter paper. Before performing studies on human subjects, we tested a number of extraction techniques from Whatman filter paper of [1- 13 C]glucose-spiked blood samples. Filter paper was prepared with 2.5% NaF solution as described below. Heparinized blood with a 7% [1- 13 C]glucose enrichment was dropped on Whatman paper previously treated with NaF as well as on untreated paper. The specimens were allowed to dry and then processed and derivatized as described below.
NaF-treated Whatman filter paper. Whatman 7.0-cm type 1 filter papers were obtained from Sigma Chemical Co. (St. Louis, MO) and sodium fluoride powder (NaF), 99.1% pure, obtained from J.T. Baker (Phillipsburg, NJ). The filter papers were dipped into a 2.5% NaF (wt/vol) solution mixed with Millipore-filtered water and allowed to air-dry overnight on a clean surface. The NaF inhibits glycolysis in blood cells and preserves the glucose collected on the filter paper during drying and sample preparation. A NaF concentration of 2.5% was chosen because it is comparable to the NaF concentration attained when blood specimens (of specified volume as indicated by manufacturer) are placed in commercially sold NaF-containing blood specimen tubes. Differences in enrichments between the specimens placed on NaFtreated as compared with untreated paper were not significant, but the amount of ethyl acetate required to dilute the derivatized specimens before the GC/MS procedure was significantly greater for the specimens extracted from the NaF-containing filter paper (p ϭ 0.04) than for those extracted from the plain filter paper, indicating that a greater amount of substrate was extracted from these papers. We did not find a significant difference in extractability of [1- 13 C]glucose from Whatman paper types 1, 4, 5, and 42.
In the first seven subjects studied, we sought to determine both the sensitivity and reproducibility to carry out a subcutaneous infusion/sampling method. In all of the early subjects, we observed one or more values from the finger stick samples that clearly reflected contamination (Fig. 1) . Many, but not all, of these spikes were noted (data not shown) at times corresponding to discontinuation of the isotope infusions and removal of isotope infusion line at the 8-h time point, suggesting investigator-induced contamination. Subsequently, measures were taken to prevent contamination, including: cleaning of the paper puncher between specimens with ethyl acetate, assaying prepared filter paper samples for isotope before using them on study day (to verify no contamination was present), and preparing the filter papers using a very stringent "clean" technique. This "clean" technique included frequent glove changes during the preparation of the paper when the glove may come into contact with other objects, drying filter paper on clean, disposable laboratory paper in areas where isotopes are not used, and taking great care on study days to keep filter papers out of contact with any surfaces. Finally, we observed a dramatic reduction in contamination after the filter papers were enveloped in laminated paper sheaths after initial drying and using warm-water soaks of subjects' hands before performing each finger stick. The traditional method of conducting in vivo stable isotope studies employs intravenous isotope infusion of [6,6-2 H 2 ]glucose and blood sampling from the contralateral arm. Because [6,6-2 H 2 ]glucose trace is not recycled back into the sampling space (1-3), it is considered to be the most valid tracer for calculating total glucose R a . Therefore, [6,6-2 H 2 ]glucose plasma enrichments were the "gold standard" to which the results of the new methods were compared.
Study design and protocol. Subjects were instructed to consume a normal diet during the 3 d preceding the study day, to ingest only water beginning at midnight the night before the study (8 h before beginning of study period), and to remain in the fasted state until completion of the study.
On the morning of the study day, subjects arrived in the Metabolic Research Unit (MRU) at the Children's Nutrition Research Center, Houston, TX, by 0700 h. Two antecubital intravenous catheters were placed: one for infusion of [6,6-2 H 2 ]glucose and one in the contralateral arm for venous blood sampling. Baseline venous and finger stick blood samples were obtained, and the MiniMed pump was set up for infusion according to the product manual for insulin infusion. Briefly, a Sof-set needle was used in the skin of the lateral part of the abdomen. Subjects remained in bed for the duration of the 11-h study period. Most subjects briefly left the bed to use the nearby bathroom once or twice during the study period, during which time special care was taken to assure continuous isotope infusion.
After baseline blood sampling, isotope infusions were initiated. Continuous infusion of [6,6-2 H 2 ]glucose (Razel Syringe Pump, Razel Scientific Instruments Inc., Stamford, CT) at a rate of 0.2 mol/kg/min (0.0364 mg ⅐ kg Ϫ1 ⅐ min
) was "piggy backed" into 0.45% saline infusion (20 mL/h). At the same time, a 10% [1- 13 C]glucose was infused subcutaneously at a rate of 350 L/h, which averaged 0.045 mol/kg/min (0.009 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ) for the five subjects used in the final analyses. Both isotopes were infused for 8 h. At the end of the 8 h of isotope infusion, both infusions were discontinued and infusion needles immediately removed to avoid any further entry of isotope into the tissues during the isotope decay portion of the study. Blood sampling was continued for an additional 3-h isotope decay period.
Both finger stick and venous blood were obtained at 0 h (immediately before starting infusions), 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 6 h 30 min, 7 h, 7 h 30 min, 8 h, 8 h 30 min, 9 h, 9 h 30 min, 10 h, 10 h 30 min, and 11 h. Our subjects tolerated the repetitive finger sticks without difficulty. A several-minute hand soak in fresh warm water in some subjects facilitated blood flow and obviated a need for a second stick. Two of our 12 subjects expressed mild discomfort with the finger sticks toward the end of the study period. Thus, in prolonged studies with repetitive finger sticks, it may be worthwhile to consider a topical anesthetic such as Emla cream to reduce discomfort.
Venous blood specimens (5 mL each) were placed immediately into EDTA tubes, placed on ice, and centrifuged (3000 rpm for 10 min at 4°C). The plasma was separated and stored at -70°C before analysis. Finger sampling sites were prepared by soaking the subject's hand in fresh, lukewarm tap water (3-5 min) and dried with a clean paper towel. The fingertip was then gently scrubbed with isopropyl alcohol and pricked with a standard disposable lancet device, as is used for self-monitoring of glucose. Blood was dropped onto NaF-impregnated filter paper (see above) of a quantity sufficient to saturate an area approximately 2 cm in diameter. The filter papers were enclosed and allowed to dry thoroughly (for a minimum of 20 min).
Sample preparation. Plasma samples were prepared as described above and analyzed as described below. A conventional, hand-held office paper puncher with the plastic reservoir removed was used to punch four 6.5-mm circles from each finger stick specimen. The paper puncher was cleaned with an ethyl acetate-saturated cotton swab between specimens to avoid crosscontamination of isotope from one specimen to the next. Using latex gloves, each set of four hole-punches was placed into a plastic microcentrifuge tube for storage at -70°C until analyzed.
Analyses. One hundred and fifty microliters of sterile deionized water was placed into each tube containing a filter paper blood specimen. The tubes were refrigerated at 4°C for 1 h, then briefly vortexed. The water solution was transferred into 1.5-mL microcentrifuge tubes. Two hundred microliters of ice-cold acetone was added to deproteinize the sample, and each tube was briefly vortexed and capped before being refrigerated again for 10 min. Specimens were centrifuged (3000 rpm at 4°C) for 10 min, and the supernatant decanted into 4-mL vials and evaporated completely under nitrogen gas. Fifty microliters acetic anhydride:pyridine (2:1) was added to each tube. The tubes were sealed tightly with a Teflon-faced cap, vortexed briefly, and heated at 60°C for 10 min. The contents were then dried under nitrogen gas and subsequently reconstituted in 30 L ethyl acetate.
The enrichment of [6,6- between study hours 7.0 and 8.0. Steady state enrichments were calculated for each subject by averaging enrichments from time points 7 h, 7.5 h, and 8 h, and mean steady state enrichments for all subjects within each of the four groups were determined based on these values.
Calculations. Steady state was defined by CV Ͻ10% and curve slope not significantly different from zero during the 7th hour of isotope infusion. CV was calculated for each subject for each isotope/sampling method (four CV Figure 1 . Contaminated finger stick glucose enrichments. This figure depicts the enrichment in finger stick and venous specimens from a single subject receiving a subcutaneous infusion of [1- 13 C]glucose and demonstrates the obvious contamination of the finger stick samples. [1- 13 ]C glucose venous (■), [1- 13 ]C glucose fingersticks (•).
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calculations per subject) using the enrichments of samples taken at 7 h, 7.5 h, and 8 h using the following equation:
CV ϭ SD of enrichments/mean of enrichments Mean CV was then determined for each isotope for each blood sampling method (four data groups). Slopes during the 7th hour of infusion were also calculated using a regression plot (Microsoft Excel v. 9.0.2720; Microsoft, Redmond, WA), and t test (see "Statistics") was used to determine whether slopes were significantly different from zero. Rate of appearance (R a ) of glucose was calculated using enrichments of each of the tracers ([6,6-2 H 2 ]glucose and [1- 13 C]glucose) in specimens obtained by each sampling method based on mean steady state enrichments using the following formula (3):
where E i is the enrichment of the infusate (99% for [1- 13 C]glucose and 98% for [6,6-2 H 2 ]glucose), E p is the enrichment of the tracer in plasma, and I is the infusion rate of the tracer (mol/kg/min).
To compare graphically the rise and fall of the plasma enrichments of the two isotopes, enrichments at each time point for each subject were converted to percentage of the calculated mean steady state enrichment. Tracer half-life (T 1/2 ) was calculated using standard formulas from 8 h to 11 h (4), based on ln of % mean steady state enrichments. Regression analysis was used to calculate the rate constant, which was defined as the slope of the decay curve converted to a linear format by using ln of each enrichment value. The half-life was calculated using the following formula derived as shown, where k ϭ rate constant (in hours):
T 1/2 ϭ ln 2/k ϭ 0.693/k Statistics. All comparisons were made assuming that the traditional intravenous infusion of [6,6-2 H 2 ]glucose and venous sampling is the correct value for glucose turnover. This is based on the facts that all labels in [6,6-2 H 2 ]glucose are lost during glycolysis and/or gluconeogenesis and as such do not re-enter the circulation (recycle) (1-3). Paired t tests were used to evaluate the new methods of infusion/sampling by comparing mean steady state enrichments, mean rates of appearance (R a ), mean half-lives for decay curves, and the difference between steady state slopes (mean enrichments at sample times 7 h, 7.5 h, and 8 h) and a line with slope zero. A value of p Յ 0.05 was considered to indicate statistical significance. Bland-Altman analysis was used to compare methods based on mean R a . All statistical analyses were performed on a personal computer using Microsoft Excel 2000 (v. 9.0.2720).
